{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:00:46Z","timestamp":1771002046821,"version":"3.50.1"},"reference-count":81,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2130,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1111\/j.1529-8019.2009.01274.x","type":"journal-article","created":{"date-parts":[[2009,11,4]],"date-time":"2009-11-04T15:35:26Z","timestamp":1257348926000},"page":"518-537","source":"Crossref","is-referenced-by-count":30,"title":["Treatment of leprosy\/Hansen's disease in the early 21st century"],"prefix":"10.1155","volume":"22","author":[{"given":"Sophie M.","family":"Worobec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB1","volume-title":"Handbook of Leprosy","author":"Jopling","year":"1988"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB2","first-page":"821","article-title":"The first decade in experimental leprosy","volume":"44","author":"Shepard","year":"1971","journal-title":"Bull W H O"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.47276\/lr.77.1.5","article-title":"The mouse foot-pad technique for cultivation of Mycobacterium leprae","volume":"77","author":"Levy","year":"2006","journal-title":"Lepr Rev"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01274.x-BIB4","first-page":"287","article-title":"Extended studies on the viability of Mycobacterium Leprae outside the human body","volume":"66","author":"Desikan","year":"1995","journal-title":"Lepr Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB5","unstructured":"5.\u2002 Davis WB , Schmidly DJ . The Mammals of Texas OnLine edition, 1994."},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(83)70206-9","article-title":"Leprosy in five armadillo handlers","volume":"9","author":"Lumpkin","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB7","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4269\/ajtmh.2008.78.962","article-title":"Case-control study of armadillo contact and Hansen's disease","volume":"78","author":"Clark","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB8","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science\/1109759","article-title":"On the origin of leprosy","volume":"308","author":"Monot","year":"2005","journal-title":"Science"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.47276\/lr.76.3.198","article-title":"Leprosy in wild armadillos","volume":"76","author":"Truman","year":"2005","journal-title":"Lepr Rev"},{"issue":"12","key":"10.1111\/j.1529-8019.2009.01274.x-BIB10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ncpneuro0941","article-title":"Nerve damage in leprosy and its management","volume":"4","author":"Wilder-Smith","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/35059006","article-title":"Massive gene decay in the leprosy bacillus","volume":"409","author":"Cole","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB12","first-page":"1021","volume-title":"Harrison's principles of internal medicine","author":"Gelber","year":"2008"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01274.x-BIB13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB14","first-page":"21.1","volume-title":"Rook's textbook of dermatology","author":"Lockwood","year":"2004"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB15","first-page":"1786","volume-title":"Fitzpatrick's dermatology in general medicine","author":"Rea","year":"2008"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1309\/AJCPP72FJZZRRVMM","article-title":"A new mycobacterium species causing diffuse lepromatous leprosy","volume":"130","author":"Han","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1067\/mjd.2003.326","article-title":"Fatal Lucio's phenomenon in 2 patients with previously undiagnosed leprosy","volume":"48","author":"Ang","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB18","first-page":"7","article-title":"A clinical and immunological study of four babies of mothers with lepromatous leprosy, two of whom developed leprosy in infancy","volume":"51","author":"Duncan","year":"1983","journal-title":"Int J Lepr"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB19","first-page":"805","article-title":"Two simultaneous cases of leprosy developing in tattoos","volume":"23","author":"Porrit","year":"1947","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB20","first-page":"112","article-title":"Leprosy transmission and mucosal immunity: towards eradication?","volume":"69","author":"Cree","year":"1998","journal-title":"Lepr Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/ije\/dyl072","article-title":"Socioeconomic, environmental, and behavioural risk factors for leprosy in North-east Brazil: results of a case-control study","volume":"35","author":"Kerr-Pontes","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB22","unstructured":"22.\u2002World Health Organization. WHO factsheet. http:\/\/www.who.int\/lep\/strategy\/wha\/en\/. Accessed June 16, 2009."},{"issue":"33","key":"10.1111\/j.1529-8019.2009.01274.x-BIB23","first-page":"293","volume":"83","author":"World Health Organization","year":"2008","journal-title":"WHO weekly epidemiological record"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB24","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/bmj.324.7352.1516","article-title":"Leprosy elimination- a virtual phenomenon or a reality?","volume":"324","author":"Lockwood","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB25","unstructured":"25.\u2002http:\/\/www.who.int\/lep\/situation\/en\/. Accessed June 2, 2009."},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB26","first-page":"97","volume-title":"Conn's current therapy","author":"Kumar","year":"2009"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2003.11.072","article-title":"An update on the diagnosis and treatment of leprosy","volume":"51","author":"Moschella","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB28","first-page":"373","article-title":"The future incidence of leprosy: a scenario analysis","volume":"82","author":"Meima","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB29","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(08)60433-X","article-title":"Leprosy strategy is about control, not eradication","volume":"371","author":"Smith","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/ije\/31.5.991","article-title":"Disappearance of leprosy from Norway: an exploration of critical factors using an epidemiological modelling approach","volume":"31","author":"Meima","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB31","unstructured":"31.\u2002A summary of Hansen's disease in the United States-2006. U.S. Department of Health and Human Services Health Resources and Services Administration National Hansen's Disease Program. http:\/\/www.hrsa.gov\/hansens\/data2006\/. Accessed June 2, 2009."},{"issue":"50","key":"10.1111\/j.1529-8019.2009.01274.x-BIB32","first-page":"449","volume":"83","author":"World Health Organization","year":"2008","journal-title":"WHO weekly epidemiological record"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB33","first-page":"1","volume-title":"Topics in human genetics","author":"Chakravartti","year":"1973"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB34","first-page":"405","article-title":"Leprosy in twins","volume":"34","author":"Mohammed","year":"1966","journal-title":"Int J Lepr"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/513830","article-title":"Susceptibility to leprosy is linked to the human NRAMP1 Gene","volume":"177","author":"Abel","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature02326","article-title":"Susceptibility to leprosy is associated with PARK2 and PACRG","volume":"427","author":"Mira","year":"2004","journal-title":"Nature"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1489\/1544-581X(2004)072<0169:LOLSTP>2.0.CO;2","article-title":"Linkage of leprosy susceptibility to Parkinson's disease genes","volume":"72","author":"Buschman","year":"2004","journal-title":"Int J Lepr Other Mycobact Infect"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10096-009-0746-0","article-title":"Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy","volume":"28","author":"Bochud","year":"2009","journal-title":"Eur J Clin Microbiol and Infect Dis"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01274.x-BIB39","first-page":"472","article-title":"Leprosy in infants-report of two cases","volume":"57","author":"Girdhar","year":"1989","journal-title":"Int J Lepr"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.47276\/lr.77.4.377","article-title":"Indeterminate leprosy in an infant","volume":"77","author":"Krishna Moorthy","year":"2006","journal-title":"Lepr Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB41","unstructured":"41.\u2002http:\/\/www.who.int\/lep\/situation\/americas\/en\/index.html. Accessed May 30, 2009."},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB42","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01274.x-BIB43","first-page":"71","article-title":"Leprosy: a primer for Canadian physicians","volume":"170","author":"Boggild","journal-title":"Can Med Assoc J"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB44","first-page":"1","article-title":"The clinical and immunological features of leprosy","author":"Walker","year":"2006","journal-title":"Br Med Bull"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB45","first-page":"134","volume-title":"Leprosy","author":"Pfaltzgraff","year":"1985"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB46","first-page":"13","volume-title":"Histologic interpretation and clinical application","author":"Ridley","year":"1977"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB47","unstructured":"47.\u2002 James WD , Berger TG , Elston DM . Chapter 17 Hansen's disease. In Andrews\u2019 diseases of the skin: clinical dermatology, 10th ed. Saunders W B Co., 2005: 343-352."},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB48","first-page":"252","volume-title":"Leprosy","author":"Barton","year":"1985"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB49","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/bmj.2.6148.1340","article-title":"Greater auricular nerve in diagnosis of leprosy","volume":"iv","author":"Lynch","year":"1978","journal-title":"Br Med J"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB50","unstructured":"50.\u2002http:\/\/www.who.int\/lep\/mdt\/regimens\/en\/index.html. Accessed June 14, 2009."},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01274.x-BIB51","first-page":"78","article-title":"Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions","volume":"69","author":"Ramu","year":"1998","journal-title":"Lepr Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB52","first-page":"2","article-title":"Is there a microbiological rationale for single-dose treatment of leprosy?","volume":"69","author":"Katoch","year":"1998","journal-title":"Lepr Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB53","unstructured":"53.\u2002World Health Organization. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006-2010; Operational Guidelines. Regional Office for South-East Asia, New Delhi, 2006."},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01274.x-BIB54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/INF.0b013e31818de21e","article-title":"Leprosy and international adoption","volume":"28","author":"King","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB55","unstructured":"55.\u2002http:\/\/www.hrsa.gov\/hansens\/clinical\/regimens.htm. Accessed June 12, 2009."},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1201\/b13916","volume-title":"Litt's drug eruption reference manual","author":"Litt","year":"2009"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB57","first-page":"185","article-title":"Intravascular hemolysis and acute renal failure following intermittent rifampin therapy","volume":"60","author":"Gupta","year":"1992","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB58","first-page":"397","article-title":"Fixed drug eruption due to rifampin","volume":"69","author":"John","year":"1998","journal-title":"Lepr Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB59","first-page":"349","volume-title":"Leprosy","author":"Jacobsen","year":"1994"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB60","first-page":"225","article-title":"The management of leprosy reversal reactions","volume":"69","author":"Britton","year":"1998","journal-title":"Lepr Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB61","first-page":"127","article-title":"The role of mycophenolate mofetil in the treatment of leprosy reactions","volume":"73","author":"Burdick","year":"2005","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB62","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/518699","article-title":"Methotrexate treatment for type 1 (reversal) leprosy reactions","volume":"45","author":"Biosca","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB63","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/archderm.140.8.997","article-title":"Immune reconstitution inflammatory syndrome associated with HIV and leprosy","volume":"140","author":"Couppie","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.47276\/lr.80.1.85","article-title":"Borderline tuberculoid leprosy with upgrading Type 1 reaction in a HIV seropositive patient, after antiretroviral therapy: an Immune Reconstitution Inflammatory Syndrome","volume":"80","author":"Kar","year":"2009","journal-title":"Lepr Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB65","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.140.9.1051","article-title":"Treatment of recurring cutaneous drug reactions in patients with human immunodeficiency virus 1 infection: a series of 3 cases","volume":"140","author":"Dolev","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB66","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/archderm.138.12.1607-a","article-title":"Painful skin nodules and epididymo-orchitis","volume":"138","author":"Ling","year":"2002","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1111\/j.1529-8019.2009.01274.x-BIB67","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMc052955","article-title":"Treatment of recurrent erythema nodosum leprosum with infliximab","volume":"355","author":"Faber","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB68","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1489\/1544-581X(2004)72<480:MIRE>2.0.CO;2","article-title":"Methotrexate in resistant ENL","volume":"72","author":"Kar","year":"2004","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB69","first-page":"105","volume-title":"Conn's current therapy","author":"Scollard","year":"2003"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB70","first-page":"182","volume-title":"Lecture notes: tropical medicine","author":"Lockwood","year":"2009"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB71","unstructured":"71.\u2002World Health Organization. WHO model prescribing information: drugs used in Leprosy. 2008. http:\/\/apps.who.int\/medicinedocs\/en\/d\/Jh2988e\/10.html. Accessed June 20, 2009."},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB72","first-page":"245","article-title":"The association of pregnancy and leprosy.1. New cases, relapse of cured patients and deterioration of patients on treatment during pregnancy and lactation-results of a prospective study of 154 pregnacies in 147 Ethiopian women","volume":"52","author":"Duncan","year":"1981","journal-title":"Lepr Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB73","first-page":"6","article-title":"Pregnancy and leprosy","volume":"67","author":"Lockwood","year":"1999","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01274.x-BIB74","first-page":"9","article-title":"Growth and development of children of mothers with leprosy and healthy controls","volume":"45","author":"Duncan","year":"2007","journal-title":"Ethiop Med J"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.47276\/lr.75.2.181","article-title":"A case of post-partum borderline tuberculoid leprosy complicated by a median nerve abscess, peptic ulceration and rifampicin-induced haemolytic renal failure","volume":"75","author":"Dawe","year":"2004","journal-title":"Lepr Rev"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB76","first-page":"559","article-title":"Epidemiologic characteristics of leprosy reactions","volume":"62","author":"Scollard","year":"1994","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB77","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1086\/505222","article-title":"Development of leprosy and Type 1 leprosy reactions after treatment with infliximab: a report of two cases","volume":"43","author":"Scollard","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01274.x-BIB78","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archdermatol.2009.10","article-title":"Type 1 leprosy reaction manifesting after discontinuation of adalimumab therapy","volume":"145","author":"Camacho","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB79","unstructured":"79.\u2002Office of Public Health, Louisiana Dept. of Health & Hospitals; Infectious Disease Epidemiology Section. Hansen's Disease (Leprosy), Oct. 8, 2004."},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB80","unstructured":"80.\u2002http:\/\/www.hrsa.gov\/hansens\/history.htm. Accessed June 9, 2009."},{"key":"10.1111\/j.1529-8019.2009.01274.x-BIB81","unstructured":"81.\u2002http:\/\/www.fortyandeight.org\/star.htm. Accessed April 29, 2009."}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2009.01274.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2009.01274.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:57:41Z","timestamp":1671818261000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2009.01274.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2009.01274.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}